Agilent Technologies Inc
Research Agilent Technologies Inc (A) on Bullrun: valuation model: 9.8% overvalued, market cap USD 48.09B, P/E 33.6, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerA
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal9.8% overvalued
- Market capUSD 48.09B
- P/E33.6
- Dividend yield0.6%
- Financial periodQ3 2026
- RevenueUSD 1.88B
- Net incomeUSD 362.00M
- Free cash flowUSD 439.00M
- Gross margin55.5%
Valuation Snapshot
Bullrun's latest valuation model marks Agilent Technologies Inc as 9.8% overvalued; latest market cap is USD 48.09B; P/E is 33.6; dividend yield is 0.6%.
Peer valuation comparison
Latest P/E is 33.58x versus a Healthcare sector median of 24.61x (36.4% above).
Latest dividend yield is 0.6% versus a Healthcare sector median of 1.84% (67.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 6.95B | USD 1.30B | USD 1.15B | 52.4% | 4.57 | USD 1.79B | USD 3.35B | USD 6.74B |
| FY2024 | USD 6.51B | USD 1.29B | USD 1.37B | 54.3% | 4.43 | USD 1.33B | USD 3.39B | USD 5.90B |
| FY2023 | USD 6.83B | USD 1.24B | USD 1.47B | 50.7% | 4.19 | USD 1.59B | USD 2.74B | USD 5.85B |
| FY2022 | USD 6.85B | USD 1.25B | USD 1.02B | 54.4% | 4.18 | USD 1.05B | USD 2.77B | USD 5.31B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 48.09B | 33.6 | 0.6% | 1.02 |
| 2025 | 2025-12-31 | USD 38.58B | 29.8 | 0.6% | 0.75 |
| 2024 | 2024-12-31 | USD 38.37B | 30.3 | 0.7% | 0.97 |
| 2023 | 2023-12-29 | USD 40.74B | 33.1 | 0.8% | 1.16 |
| 2022 | 2022-12-30 | USD 44.31B | 35.8 | 0.7% | 1.07 |
| 2021 | 2021-12-31 | USD 48.21B | 40.4 | 0.5% | 0.76 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.02 USD, yield 0.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.99 USD |
| FY2024 | 0.94 USD |
| FY2023 | 0.9 USD |
| FY2022 | 0.84 USD |
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.
ETFs that hold Agilent Technologies Inc
Agilent Technologies Inc is one of the ten largest holdings of 14 ETFs that investors in Europe can buy. The 8 most traded of them:
Compare every fund on the same index:
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Agilent Technologies Inc overvalued or undervalued?
Bullrun's valuation model currently marks Agilent Technologies Inc as 9.8% overvalued.
What is Agilent Technologies Inc's market cap?
Agilent Technologies Inc's market capitalization is USD 48.09B.
What is Agilent Technologies Inc's P/E ratio?
Agilent Technologies Inc's price-to-earnings (P/E) ratio is 33.6.
Does Agilent Technologies Inc pay a dividend?
Agilent Technologies Inc has a dividend yield of 0.6%.
What does Agilent Technologies Inc do?
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses.